The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations of age, PD-L1 status, BRAF mutation and tumor mutational burden (TMB) in advanced melanoma.
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Genentech/Roche; Genentech/Roche; Incyte; Newlink Genetics; Novartis
Speakers' Bureau - Genentech/Roche; Merck
 
Shaojun Tang
No Relationships to Disclose
 
Kelsey Poorman
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Anthony J. Olszanski
Consulting or Advisory Role - Bristol-Myers Squibb; G1 Therapeutics; Merck; Takeda
Research Funding - Advaxis (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ignyta (Inst); Immunocore (Inst); Incyte (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Burton Larry Eisenberg
No Relationships to Disclose
 
Inderjit Mehmi
Speakers' Bureau - Bristol-Myers Squibb
 
Jeffrey M. Farma
Consulting or Advisory Role - Amgen; Castle Biosciences
 
Gino Kim In
No Relationships to Disclose
 
Asim Amin
Consulting or Advisory Role - Merck
Speakers' Bureau - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Merck
 
Suthee Rapisuwon
Research Funding - Bristol-Myers Squibb
 
Ari M. Vanderwalde
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Millennium; Polynoma
Travel, Accommodations, Expenses - Caris Life Sciences
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Alexion Pharmaceuticals; Argos Therapeutics; Array BioPharma; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celldex; Eisai; Exelixis; Genentech; Glactone Pharma; Idera; Merck; Nektar; Novartis; Peleton; Pfizer; X4 Pharma